Novavax (NVAX) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free NVAX Stock Alerts $15.03 -0.22 (-1.44%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 7:38 AM | americanbankingnews.comNovavax (NASDAQ:NVAX) Shares Gap Down to $15.52May 30 at 9:25 AM | prnewswire.comNovavax to Participate in 2024 Jefferies Global Healthcare ConferenceMay 28 at 1:25 PM | marketbeat.comNovavax (NASDAQ:NVAX) Trading Down 12.6%Novavax (NASDAQ:NVAX) Stock Price Down 12.6%May 28 at 12:53 PM | benzinga.comSmart Money Is Betting Big In NVAX OptionsMay 24, 2024 | finance.yahoo.comArbutus, Novavax See Activist Investor ActionMay 24, 2024 | reuters.comNovavax awaits FDA decision on whether its next COVID shot can be offered in USMay 24, 2024 | fool.comWhy Vaccine Stocks Rallied This WeekMay 24, 2024 | americanbankingnews.comNovavax (NASDAQ:NVAX) PT Raised to $29.00 at B. RileyMay 23, 2024 | benzinga.comNovavax Unusual Options Activity For May 23May 23, 2024 | finance.yahoo.comHeard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your ChicksMay 23, 2024 | marketbeat.comB. Riley Increases Novavax (NASDAQ:NVAX) Price Target to $29.00B. Riley raised their price objective on Novavax from $11.00 to $29.00 and gave the stock a "buy" rating in a research note on Thursday.May 23, 2024 | investorplace.comThe Next Novavax? 3 Biopharma Stocks to Buy Before They BoomMay 23, 2024 | americanbankingnews.comNovavax (NASDAQ:NVAX) Sets New 1-Year High at $15.69May 23, 2024 | americanbankingnews.comNovavax Sees Unusually Large Options Volume (NASDAQ:NVAX)May 22, 2024 | msn.comShah Capital Ends Proxy Fight at Novavax After Sanofi Deal BoostMay 22, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Trading 3.4% Higher Novavax (NASDAQ:NVAX) Shares Up 3.4%May 22, 2024 | marketbeat.comTraders Purchase High Volume of Novavax Call Options (NASDAQ:NVAX)Novavax, Inc. (NASDAQ:NVAX - Get Free Report) saw some unusual options trading on Wednesday. Stock traders purchased 37,307 call options on the stock. This is an increase of approximately 70% compared to the typical volume of 21,990 call options.May 22, 2024 | investorplace.com3 Biotech Stocks to Buy Now: May 2024May 22, 2024 | fool.comBetter Buy: Inovio Pharmaceuticals vs. NovavaxMay 22, 2024 | fool.com3 Things You Need to Know If You Buy Novavax TodayMay 22, 2024 | marketbeat.comBNP Paribas Financial Markets Increases Stock Position in Novavax, Inc. (NASDAQ:NVAX)BNP Paribas Financial Markets raised its holdings in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 48.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 861,479 shares of the biopharmaceutical companMay 20, 2024 | markets.businessinsider.comShah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual MeetingMay 20, 2024 | reuters.comShah Capital ends campaign against Novavax board after Sanofi dealMay 19, 2024 | fool.comThis Stock Just More Than Doubled in 1 Day: Is It a Buy?May 18, 2024 | fool.comIs Novavax Stock a Buy?May 17, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Stock Price Down 8.8%Novavax (NASDAQ:NVAX) Stock Price Down 8.8%May 17, 2024 | forbes.comUp 3x In A Week Will Novavax Stock Continue To See Higher Levels?May 17, 2024 | fool.comCould Novavax Become the Next Moderna?May 16, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Shares Up 12.4%Novavax (NASDAQ:NVAX) Shares Up 12.4%May 16, 2024 | insidertrades.comNovavax, Inc. (NASDAQ:NVAX) Insider Sells $657,636.80 in StockMay 16, 2024 | fool.comIf You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have NowMay 16, 2024 | investorplace.comAnalyst Upgrades: 3 Stocks Getting the Nod From Pros Last WeekMay 15, 2024 | benzinga.comNovavax's Options: A Look at What the Big Money is ThinkingMay 15, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Shares Gap Down to $13.48Novavax (NASDAQ:NVAX) Shares Gap Down to $13.48May 15, 2024 | fool.com1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?May 15, 2024 | fool.com2 Incredible Growth Stocks to Buy Hand Over Fist Right NowMay 15, 2024 | finance.yahoo.comZacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and NvidiaMay 15, 2024 | fool.comNovavax Stock Just Tripled. Is It Too Late to Buy?May 14, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Sees Large Volume Increase on Analyst UpgradeNovavax (NASDAQ:NVAX) Sees Large Volume Increase After Analyst UpgradeMay 14, 2024 | investorplace.com3 Cheap Biotech Stocks to Buy Now: May 2024May 14, 2024 | marketbeat.com5 Meme Stocks With a High Short InterestNo, it's not 2021. But waking up today, you might have been forgiven for thinking so.May 14, 2024 | marketbeat.com5 Meme Stocks With a High Short Interest (NVAX)Keith Gill, aka RoaringKitty, resurfaces on Twitter, triggering a surge in GameStop and AMC Entertainment shares amid remarkable trading volume.May 14, 2024 | fool.comDoes Soaring Novavax Stock Have Enough Fuel to Climb Higher?May 13, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Shares Gap Up Following Analyst UpgradeNovavax (NASDAQ:NVAX) Shares Gap Up Following Analyst UpgradeMay 13, 2024 | prnewswire.comNovavax to Participate in BofA Securities 2024 Health Care ConferenceMay 13, 2024 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from AnalystsShares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have been assigned an average recommendation of "Hold" from the five ratings firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buy recMay 13, 2024 | cnbc.comNovavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine makerMay 13, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Price Target Raised to $10.00TD Cowen lifted their price target on shares of Novavax from $5.00 to $10.00 and gave the company a "hold" rating in a research report on Monday.May 13, 2024 | finance.yahoo.comNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Novavax (NASDAQ:NVAX)HC Wainwright reissued a "buy" rating and issued a $19.00 target price on shares of Novavax in a report on Monday. Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. NVAX Media Mentions By Week NVAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.630.82▲Average Medical News Sentiment NVAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼89▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Twist Bioscience News Denali Therapeutics News Iovance Biotherapeutics News Relay Therapeutics News Adaptive Biotechnologies News Kodiak Sciences News CRISPR Therapeutics News Exelixis News Halozyme Therapeutics News Ionis Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeWho are Nvidia’s New Silent Partners?Weiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
